IL-6 is highly expressed in human cervical cancer promoting tumorigenesis by activation of the JAK/STAT3 pathway, subsequent upregulation of vascular endothelial growth factor (VEGF) and increased angiogenesis [55]. The gene discussed is VEGFA; the disease is cervical cancer.